Datatrak Intl Inc (DTRK) 6.7500 $DTRK DATATRAK to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Datatrak Intl Inc (DTRK) 6.7500 $DTRK

DATATRAK to Feature CTMS and Full Platform at Upcoming DIA 2016
PR Newswire - Thu Jun 16, 12:45PM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced the full DATATRAK platform with an emphasis on the new CTMS solution, UX CTMS 360(TM), will be featured at DIA 2016.

Reduce Queries up to 90% with Integrated Imaging and EDC Technology
PR Newswire - Mon Jun 06, 7:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced the completion of a case study analyzing the partnership between DATATRAK and AG Mednet to successfully reduce queries by 90% in a recent trial with integrated technology.

Jim Bob Ward Named CEO of DATATRAK
PR Newswire - Mon May 23, 8:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, today announced that interim CEO and founder of the software platform, Jim Bob Ward, has been named CEO and President.

DATATRAK International, Inc. Reports First Quarter Results of 2016
PR Newswire - Tue May 10, 8:00AM CDT
DATATRAK International, Inc. (OTC Markets: DTRK), a leader in cloud-based, unified dClinical® technologies and related services for the clinical trials industry, today announced its operating results for the first quarter of 2016.

DATATRAK International, Inc. Reports Fourth Quarter and Full Year Results of 2015
PR Newswire - Fri Apr 08, 5:33PM CDT
DATATRAK International, Inc. (OTCQX: DTRK), a leader in cloud-based, unified dClinical® technologies and related services for the clinical trials industry, today announced its operating results for the fourth quarter and full year 2015.

DATATRAK International, Inc., Timothy G. Biro, James M. Karis, Jerome H. Kaiser, Nicholas A. Loiacono, Tabatabai Investment Management LLC (f/k/a Arosa Investment Management LLC) and Alex Tabatabai Seek Court Approval of Proposed Settlement
PR Newswire - Mon Mar 07, 4:03PM CST
Pursuant to Ohio Rule of Civil Procedure 23.1 DATATRAK International, Inc. (OTCQX: DTRK), Timothy G. Biro, James M. Karis, Jerome H. Kaiser, Nicholas A. Loiacono and Andrew T. Pitler (collectively the "Released DATATRAK Parties" on the one hand, and Tabatabai Investment Management LLC (f/k/a Arosa Investment Management LLC and Alex Tabatabai (collectively "Arosa" (collectively the "Settling Parties" on the other, hereby provide notice to DATATRAK Shareholders of a proposed partial settlement of DATATRAK International, Inc. v. Arosa Investment Management, LLC, et al., Cuyahoga County Court of Common Pleas Case No. CV-15-854059, currently being considered for final approval by the Honorable Michael E. Jackson (the "Proposed Settlement". The Proposed Settlement does not include former DATATRAK Chairman Laurence P. Birch, and the claims asserted by Arosa against Mr. Birch survive the Proposed Settlement.

DATATRAK & NTT Data Host Tokyo User Group Meeting
Marketwired - Wed Feb 03, 4:10PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies, today announced its participation in the FIRST NTT Data User Group meeting held in Tokyo, Japan.

DATATRAK's Technology Driven Drug Development (TD3) Supports Clinical Trial Industry Transformation
Marketwired - Thu Jan 14, 11:06AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that more than 100 CROs, 10 of the top 15 pharmaceutical organizations, and 3 top 10 biotechs, are using the DATATRAK ONE UX(TM) platform in their efforts to harness technology to drive drug development.

Arosa Investment Management Thanks Datatrak Shareholders and Vows to Faithfully Represent Their Best Interests
BusinessWire - Wed Jan 13, 12:24PM CST
Arosa Investment Management LLC wishes to express its gratitude for the outpouring of support from a broad base of shareholders over the prolonged election process that spilled over into a new year, included three scheduled meeting dates and required shareholders to submit ballots at least twice. Here are the figures from IVS Associates' Final Report of the Inspector of Elections:

DATATRAK Welcomes New Directors
Marketwired - Tue Jan 12, 5:11PM CST
Three new directors have been elected to the board of DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry. Prior to the next meeting of the Board of Directors, the Company also reiterated its commitment to serving its customers and remains optimistic about the Company's long-term opportunity to grow and thrive in the future.

Statement From DATATRAK's Board Regarding Annual Meeting and the Call to Work Constructively Going Forward
Marketwired - Thu Jan 07, 1:09PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today released a statement from its three Class II Directors who will remain in office regardless of the results of tomorrow's Annual Meeting of Shareholders.

Arosa Investment Management Alerts Shareholders to the Datatrak Board's Secretive Adoption of Golden Parachutes and By-law Amendments
BusinessWire - Wed Jan 06, 7:16PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTCTRK) that initiated a proxy contest and obtained the most votes at two scheduled annual meetings that Datatrak management abruptly postponed, is alerting shareholders to the Datatrak board's secretive and shameless last-minute adoption of golden parachutes and by-law amendments.

DATATRAK Announces Settlement of Patent Litigation
Marketwired - Wed Jan 06, 8:02AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that it has entered into a settlement agreement with Medidata Solutions, Inc. to resolve all existing patent litigation between the parties.

Survey Says - DATATRAK Customer-Centric Approach Works
PR Newswire - Mon Jan 04, 9:32PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that results from an internal client survey confirm that DATATRAK's customer-centric approach to clinical trial solutions has had a positive impact.

Arosa Investment Management Again Refutes Datatrak's Shameless and Phony Campaign of Misinformation Targeted Against Arosa
BusinessWire - Mon Jan 04, 5:59PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTCTRK) that initiated a proxy contest and obtained the most votes at two scheduled annual meetings that Datatrak management abruptly postponed, again refutes Datatrak's shameless and phony campaign of misinformation targeted against Arosa.

DATATRAK Urges Shareholders To Reject Arosa's Claims
PR Newswire - Thu Dec 31, 3:23PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today called upon the shareholders to review the following information and reject Arosa's claims.

DATATRAK Technology and Clinical Research Expertise Bests Competitors
PR Newswire - Wed Dec 30, 7:53PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced top ranking content in the Clinical Leader Top 10 of 2015. A total of 5 DATATRAK authored articles were highlighted in the annual recap, more than any other source, with top spots in the White Paper and Case Study categories.

Arosa Investment Management Calls on Datatrak to Comply with Law and Stop Endless Delay and Entrenchment Actions; Calls on Chairman/CEO Larry Birch to Immediately Resign
BusinessWire - Wed Dec 30, 3:06PM CST
Arosa Investment Management LLC, the beneficial owner of approximately 9.9% of the shares of Datatrak International, Inc. (OTCTRK) that initiated a proxy contest and has now obtained the most votes at two scheduled Annual Meetings that Datatrak management has abruptly delayed, calls on Datatrak to immediately hold the 2015 Annual Meeting and calls on Chairman/CEO Larry Birch to immediately resign.

DATATRAK Uncovers Smoking Gun Evidence Tying Alex Tabatabai to Serious Misconduct
PR Newswire - Tue Dec 29, 8:45PM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that the 2015 Annual Meeting of Shareholders has been postponed and will now take place at 10:00 am CT on Friday, January 8, 2015 at the Prudential Plaza Building, 180 North Stetson, Suite 1630, Chicago, IL 60601.

DATATRAK Files Motion To Dismiss Arosa's Specious Claims Relating To The Postponed Annual Meeting
PR Newswire - Tue Dec 22, 7:00AM CST
DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical(TM) technologies and delivering related services for the clinical trials industry, today announced that the Company has filed a motion to have the dissident's claims dismissed regarding previous postponement of the annual meeting.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 99

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 27

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 235

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 335

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 254

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 148

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 489

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Albion KAY VCT PLC's Strong Half-Year Performance Review

Updated Category News Views 95

Overview of Albion KAY VCT PLC Albion KAY VCT PLC plays a critical role in the investment landscape. The Company has recently published its Half-yearly Financial Report, which has garnered significant interest from both shareholders and potential investors. This report provides an in-depth look at the Company’s operations and financial condition over the six months...

Continue Reading
BlackRock Inc. Acknowledges Significant Stake in Syensqo

Updated Category News Views 160

Participation Notification by BlackRock Inc. In a recent communication, BlackRock Inc. has informed Syensqo of their increase in voting rights ownership, surpassing the critical threshold of 3%. This change is attributed to recent acquisitions or disposals of voting securities, which is in line with European transparency regulations. Details of the Notification The...

Continue Reading
Black Kite Unveils Innovative Global AI Risk Assessment Nexus

Updated Category News Views 204

Black Kite Launches Groundbreaking AI Assessment Framework Black Kite's GA³™ framework addresses a significant void in current global assurance frameworks. It creates a comprehensive standard that adapts to the ever-changing AI threat landscape. Importance of AI Risk Management Frameworks As cyber threats evolve, organizations face challenges in third-party risk...

Continue Reading
Purdue University Leads All-Boilermaker Mission with Virgin Galactic

Updated Category News Views 255

Purdue University Embarks on a Landmark Space Mission Building upon its rich legacy in space exploration, Purdue University is poised to undertake a remarkable journey — an all-Boilermaker crew will participate in a Virgin Galactic suborbital spaceflight known as Purdue 1. Set to launch in the near future, this mission opens up new avenues for academic exploration in...

Continue Reading
LP Building Solutions Provides Update on Q3 2024 Earnings Call

Updated Category News Views 77

LP Building Solutions Reveals Q3 2024 Earnings Call Details LP Building Solutions (NYSE: LPX), a prominent player in the building materials sector, has officially announced the schedule for its earnings conference call, set for an upcoming Tuesday. This anticipated event will highlight the financial results for the third quarter of 2024. Important Conference Call...

Continue Reading